Literature DB >> 22884897

Role of mGluR4 in acquisition of fear learning and memory.

Matthew J Davis1, Ovidiu D Iancu, Francine C Acher, Blair M Stewart, Massarra A Eiwaz, Robert M Duvoisin, Jacob Raber.   

Abstract

Group III metabotropic glutamate receptors (mGluRs), which are generally located presynaptically, modulate synaptic transmission by regulating neurotransmitter release. Previously we showed enhanced amygdala-dependent cued fear conditioning in mGluR4(-/-) mice 24 h following training involving two tone-shock pairings. In this study, we assessed the effects of modulating mGluR4 signaling on acquisition and extinction of conditioned fear. mGluR4(-/-) and wild-type female and male mice received 10 tone-shock pairings during training. Compared to wild-type mice, mGluR4(-/-) mice showed enhanced acquisition and extinction of cued fear. Next, we assessed whether acute pharmacological stimulation of mGluR4 with the specific orthosteric mGluR4 agonist LSP1-2111 also affects acquisition and extinction of cued fear. Consistent with the enhanced acquisition of cued fear in mGluR4(-/-), LSP1-2111, at 2.5 and 5 mg/kg, inhibited acquisition of cued fear conditioning in wild-type male mice. The drug's effect on extinction was less clear and only a subtle effect was seen at 5 mg/kg. Finally, analysis of microarray data of amygdala tissues from mGluR4(-/-) versus wild-type and from wild-type mice treated with a mGluR4 agonist versus saline revealed a significant overlap in pattern of gene expression. Together, these data support a role for mGluR4 signaling in acquisition of fear learning and memory. This article is part of a Special Issue entitled 'Metabotropic Glutamate Receptors'.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22884897      PMCID: PMC3508079          DOI: 10.1016/j.neuropharm.2012.07.038

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  35 in total

Review 1.  Neurobiology of Pavlovian fear conditioning.

Authors:  S Maren
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Extinction learning in humans: role of the amygdala and vmPFC.

Authors:  Elizabeth A Phelps; Mauricio R Delgado; Katherine I Nearing; Joseph E LeDoux
Journal:  Neuron       Date:  2004-09-16       Impact factor: 17.173

3.  A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential.

Authors:  Cyril Goudet; Bruno Vilar; Tiphanie Courtiol; Thierry Deltheil; Thomas Bessiron; Isabelle Brabet; Nadia Oueslati; Delphine Rigault; Hugues-Olivier Bertrand; Heather McLean; Hervé Daniel; Marianne Amalric; Francine Acher; Jean-Philippe Pin
Journal:  FASEB J       Date:  2012-01-05       Impact factor: 5.191

4.  ROC analysis with multiple classes and multiple tests: methodology and its application in microarray studies.

Authors:  Jialiang Li; Jason P Fine
Journal:  Biostatistics       Date:  2008-02-27       Impact factor: 5.899

5.  mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity.

Authors:  M Fendt; S Schmid; D R Thakker; L H Jacobson; R Yamamoto; K Mitsukawa; R Maier; F Natt; D Hüsken; P H Kelly; K H McAllister; D Hoyer; H van der Putten; J F Cryan; P J Flor
Journal:  Mol Psychiatry       Date:  2007-08-21       Impact factor: 15.992

Review 6.  Metabotropic glutamate receptors as novel targets for anxiety and stress disorders.

Authors:  Chad J Swanson; Mark Bures; Michael P Johnson; Anni-Maija Linden; James A Monn; Darryle D Schoepp
Journal:  Nat Rev Drug Discov       Date:  2005-02       Impact factor: 84.694

7.  Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.

Authors:  Colleen M Niswender; Kari A Johnson; C David Weaver; Carrie K Jones; Zixiu Xiang; Qingwei Luo; Alice L Rodriguez; Joy E Marlo; Tomas de Paulis; Analisa D Thompson; Emily L Days; Tasha Nalywajko; Cheryl A Austin; Michael Baxter Williams; Jennifer E Ayala; Richard Williams; Craig W Lindsley; P Jeffrey Conn
Journal:  Mol Pharmacol       Date:  2008-07-29       Impact factor: 4.436

8.  Amphetamine and extinction of cued fear.

Authors:  Stephanie A Carmack; Suzanne C Wood; Stephan G Anagnostaras
Journal:  Neurosci Lett       Date:  2009-10-21       Impact factor: 3.046

9.  GSEA-P: a desktop application for Gene Set Enrichment Analysis.

Authors:  Aravind Subramanian; Heidi Kuehn; Joshua Gould; Pablo Tamayo; Jill P Mesirov
Journal:  Bioinformatics       Date:  2007-07-20       Impact factor: 6.937

10.  Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists.

Authors:  Pauline Sibille; Sébastien Lopez; Isabelle Brabet; Ornella Valenti; Nadia Oueslati; Florence Gaven; Cyril Goudet; Hugues-Olivier Bertrand; Jacques Neyton; Michael J Marino; Marianne Amalric; Jean-Philippe Pin; Francine C Acher
Journal:  J Med Chem       Date:  2007-06-28       Impact factor: 7.446

View more
  13 in total

Review 1.  Heterogeneity and individuality: microRNAs in mental disorders.

Authors:  Leif G Hommers; Katharina Domschke; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2014-11-14       Impact factor: 3.575

2.  Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic glutamate receptor 4.

Authors:  C Zussy; X Gómez-Santacana; X Rovira; D De Bundel; S Ferrazzo; D Bosch; D Asede; F Malhaire; F Acher; J Giraldo; E Valjent; I Ehrlich; F Ferraguti; J-P Pin; A Llebaria; C Goudet
Journal:  Mol Psychiatry       Date:  2016-12-20       Impact factor: 15.992

3.  Qualification of LSP1-2111 as a Brain Penetrant Group III Metabotropic Glutamate Receptor Orthosteric Agonist.

Authors:  Manuel Cajina; Megan Nattini; Dekun Song; Gennady Smagin; Erling B Jørgensen; Gamini Chandrasena; Christoffer Bundgaard; Dorthe Bach Toft; Xinyan Huang; Francine Acher; Dario Doller
Journal:  ACS Med Chem Lett       Date:  2013-12-12       Impact factor: 4.345

Review 4.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

5.  Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders.

Authors:  Mikhail Kalinichev; Emmanuel Le Poul; Christelle Boléa; Françoise Girard; Brice Campo; Massimiliano Fonsi; Isabelle Royer-Urios; Susan E Browne; Jason M Uslaner; Matthew J Davis; Jacob Raber; Robert Duvoisin; Simon T Bate; Ian J Reynolds; Sonia Poli; Sylvain Celanire
Journal:  J Pharmacol Exp Ther       Date:  2014-06-19       Impact factor: 4.030

6.  miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.

Authors:  Juan Pablo Lopez; Raymond Lim; Cristiana Cruceanu; Liam Crapper; Caroline Fasano; Benoit Labonte; Gilles Maussion; Jennie P Yang; Volodymyr Yerko; Erika Vigneault; Salah El Mestikawy; Naguib Mechawar; Paul Pavlidis; Gustavo Turecki
Journal:  Nat Med       Date:  2014-06-08       Impact factor: 53.440

7.  Age-Related Declines in Prefrontal Cortical Expression of Metabotropic Glutamate Receptors that Support Working Memory.

Authors:  Caesar M Hernandez; Joseph A McQuail; Miranda R Schwabe; Sara N Burke; Barry Setlow; Jennifer L Bizon
Journal:  eNeuro       Date:  2018-06-28

8.  A pilot study on differential expression of microRNAs in the ventromedial prefrontal cortex and serum of sows in activity restricted crates or activity free pens.

Authors:  Guoan Yin; Liwei Guan; Langchao Yu; Dapeng Huang
Journal:  Asian-Australas J Anim Sci       Date:  2019-04-15       Impact factor: 2.509

Review 9.  The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders.

Authors:  Daniel Peterlik; Peter J Flor; Nicole Uschold-Schmidt
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

10.  Prefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats.

Authors:  Yun-Qiang Wan; Jian-Guo Feng; Mao Li; Mao-Zhou Wang; Li Liu; Xueru Liu; Xiao-Xia Duan; Chun-Xiang Zhang; Xiao-Bin Wang
Journal:  Exp Mol Med       Date:  2018-10-29       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.